A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Glutamatergic neurotransmission in schizophrenia: a systematic review protocol of 1H-MRS studies throughout phenotypic stages of schizophrenia
[post]
2020
unpublished
Schizophrenia is a significant mental health condition involving the dysregulation of multiple neurological pathways in its pathophysiology. The glutamate hypothesis for schizophrenia suggests a dysfunctional glutamatergic system throughout the varying phenotypic stages of schizophrenia – i.e. first-episode psychosis, chronic schizophrenia, and treatment-resistant schizophrenia. In this systematic review protocol (based on PRSIMA-P guidelines), we outline an approach to explore the relationship
doi:10.31234/osf.io/af8ns
fatcat:ns6csafs6jhlferjpuls7btqfm